wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38862695-34E1A9C1-1F63-4FFF-AA43-9DCF3250712E
Q38862695-34E1A9C1-1F63-4FFF-AA43-9DCF3250712E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38862695-34E1A9C1-1F63-4FFF-AA43-9DCF3250712E
Short-term efficacy and safety of new biological agents targeting the interleukin-23-T helper 17 pathway for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis.
P2860
Q38862695-34E1A9C1-1F63-4FFF-AA43-9DCF3250712E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38862695-34E1A9C1-1F63-4FFF-AA43-9DCF3250712E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2220f713fd1cbd87944631f9fc1707719cce5842
P2860
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.